International donors to pledge 13.8 billion euros to tackle AIDS: Macron
International donors have agreed to pledge 13.8 billion euros ($15.21 billion) to tackle AIDS, French President Emmanuel Macron said on Thursday.
[Global Fund] Lyon, France -At the opening of the Sixth Replenishment conference, the Global Fund announced a range of private sector partners that will spur innovation to accelerate the end to HIV, tuberculosis and malaria, the world's deadliest infectious diseases.
Publication date: Available online 22 October 2019Source: Social Science &MedicineAuthor(s): Abigail M. Hatcher, Andrew Gibbs, Ruari McBride, Dumisani Rebombo, Mzwakhe Khumalo, Nicola ChristofidesAbstractMen whose sexual behaviors place them at risk of HIV often exhibit a “cluster” of behaviors, including alcohol misuse and violence against women. Called the “Substance Abuse, Violence and AIDS (SAVA) syndemic,” this intersecting set of issues is poorly understood among heterosexual men in sub-Saharan Africa. We aim to determine cross-sectional associations between men's use of alcohol, violence,...
[Ghanaian Times] Ho -CHURCHES have no moral authority to prevent people living with HIV from tying the knot, according Rev. Dr E. A. K. Amey, clerk of the General Assembly of the E.P. Church, Ghana.
Is switching to this dual regimen an effective strategy for older HIV patients with toxicity concerns or comorbidities?HIV Medicine
[Daily Trust] The Federal Government has pledged $12 million to the Global Fund to tackle HIV, tuberculosis and malaria.
Nov 7, 2019. . Sponsored by Centers for Disease Control and Prevention, Health Resources and Services Administration, Rural Health Information Hub
Condition: HIV-1 Infection Intervention: Other: Samplings Sponsors: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); ViiV Healthcare Not yet recruiting
In recent years HIV prevention science has been revolutionized by the realization that some of the drugs originally approved to treat HIV infection are also very effective at preventing HIV infection in people considered at high risk, such as those with HIV-positive partners. Known as “pre-exposure prophylaxis” or “PreP”, the HIV medication Truvada (tenofivir plus an older antiviral called emtricitabine) is now taken on a daily basis by millions of people worldwide in order to prevent HIV infection. While optimists see PreP as an important step on the road to “ending AIDS”, critics note ...
[Premium Times] The Coalition of Civil Society Network for HIV/AIDS in Nigeria has said that increased funding for curative and preventive intervention for HIV/AIDS will give rise to zero level response in Nigeria.
Exposures to combined antiretroviral therapy (cART) as well as to human immunodeficiency virus (HIV) infection have an impact on the development of subclinical and clinical atherosclerosis, consecutively. Intima-media thickness (IMT) is used to detect the presence of subclinical atherosclerosis. A number of studies showed that atherosclerotic lesions and plaque formations in the carotid arteries are weakly associated with plaques in other peripheral arteries. Thus, the aim of this study was to compare the prevalence of atherosclerotic plaques and subclinical atherosclerosis in the carotid and femoral arteries in HIV/AIDS p...